ZA200407549B - A photoprotective orally administrable compositionfor skin. - Google Patents
A photoprotective orally administrable compositionfor skin. Download PDFInfo
- Publication number
- ZA200407549B ZA200407549B ZA200407549A ZA200407549A ZA200407549B ZA 200407549 B ZA200407549 B ZA 200407549B ZA 200407549 A ZA200407549 A ZA 200407549A ZA 200407549 A ZA200407549 A ZA 200407549A ZA 200407549 B ZA200407549 B ZA 200407549B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- lactic acid
- yeast
- bifidobacterium
- acid bacterium
- Prior art date
Links
- 230000003711 photoprotective effect Effects 0.000 title claims description 32
- 239000000203 mixture Substances 0.000 claims description 84
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 58
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 32
- 241000894006 Bacteria Species 0.000 claims description 29
- 235000014655 lactic acid Nutrition 0.000 claims description 29
- 239000004310 lactic acid Substances 0.000 claims description 29
- 239000006041 probiotic Substances 0.000 claims description 27
- 235000018291 probiotics Nutrition 0.000 claims description 27
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical group ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 25
- 230000000529 probiotic effect Effects 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 22
- 230000005855 radiation Effects 0.000 claims description 20
- 239000012228 culture supernatant Substances 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 7
- 230000004224 protection Effects 0.000 claims description 7
- 241000186000 Bifidobacterium Species 0.000 claims description 6
- 241000235070 Saccharomyces Species 0.000 claims description 6
- 235000021466 carotenoid Nutrition 0.000 claims description 6
- 150000001747 carotenoids Chemical class 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 5
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 5
- 241001608472 Bifidobacterium longum Species 0.000 claims description 5
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 5
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 5
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 5
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 5
- 208000017520 skin disease Diseases 0.000 claims description 5
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 4
- 241000186012 Bifidobacterium breve Species 0.000 claims description 4
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 4
- 241001134772 Bifidobacterium pseudocatenulatum Species 0.000 claims description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 4
- 241000235035 Debaryomyces Species 0.000 claims description 4
- 241000235649 Kluyveromyces Species 0.000 claims description 4
- 241000186660 Lactobacillus Species 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 4
- 241000235013 Yarrowia Species 0.000 claims description 4
- 241000235017 Zygosaccharomyces Species 0.000 claims description 4
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 4
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 239000013589 supplement Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000015140 cultured milk Nutrition 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 235000015243 ice cream Nutrition 0.000 claims description 2
- 239000006194 liquid suspension Substances 0.000 claims description 2
- 239000008176 lyophilized powder Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims description 2
- 235000010603 pastilles Nutrition 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 229940127557 pharmaceutical product Drugs 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000013618 yogurt Nutrition 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 7
- 241000186604 Lactobacillus reuteri Species 0.000 claims 3
- 229940001882 lactobacillus reuteri Drugs 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 33
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 16
- 230000000694 effects Effects 0.000 description 8
- 230000003449 preventive effect Effects 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 229920002774 Maltodextrin Polymers 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 5
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 5
- 229960004999 lycopene Drugs 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 4
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 235000012661 lycopene Nutrition 0.000 description 4
- 239000001751 lycopene Substances 0.000 description 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 2
- 241001134770 Bifidobacterium animalis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- FKUISVKPMQSWTN-UHFFFAOYSA-N Kesselringine Natural products C1CC(C2=C34)N(C)CCC2=CC(O)=C4OC2(OC)C(O)CCC31C2 FKUISVKPMQSWTN-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229940118852 bifidobacterium animalis Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000012505 colouration Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000033 toxigenic Toxicity 0.000 description 1
- 230000001551 toxigenic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075701 | 2002-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200407549B true ZA200407549B (en) | 2005-10-11 |
Family
ID=27741184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200407549A ZA200407549B (en) | 2002-02-21 | 2004-09-20 | A photoprotective orally administrable compositionfor skin. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20050106131A1 (de) |
| EP (1) | EP1490077B1 (de) |
| JP (1) | JP2005525348A (de) |
| KR (1) | KR20040096605A (de) |
| CN (1) | CN1635897A (de) |
| AR (1) | AR038592A1 (de) |
| BR (1) | BR0307839A (de) |
| CA (1) | CA2476730C (de) |
| DE (1) | DE60317646T2 (de) |
| DK (1) | DK1490077T3 (de) |
| ES (1) | ES2297181T3 (de) |
| MX (1) | MXPA04008182A (de) |
| NO (1) | NO20043873L (de) |
| PL (1) | PL372274A1 (de) |
| PT (1) | PT1490077E (de) |
| RU (1) | RU2314112C2 (de) |
| TW (1) | TW200303211A (de) |
| UA (1) | UA78547C2 (de) |
| WO (1) | WO2003070260A1 (de) |
| ZA (1) | ZA200407549B (de) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2309760C2 (ru) * | 2002-02-21 | 2007-11-10 | Сосьете Де Продюи Нестле С.А. | Композиция для фотопротекции кожи |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| FR2872047B1 (fr) * | 2004-06-23 | 2007-06-15 | Oreal | Composition pour peaux sensibles associant cation mineral et probiotique(s) |
| MXPA06015184A (es) * | 2004-06-23 | 2007-11-22 | Nestec Sa | Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas. |
| EP1642570A1 (de) * | 2004-10-04 | 2006-04-05 | L'oreal | Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut |
| EP1731137A1 (de) * | 2005-06-08 | 2006-12-13 | Nestec S.A. | Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut |
| FR2876029B1 (fr) * | 2004-10-04 | 2008-11-14 | Oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles. |
| MX2007004135A (es) * | 2004-10-04 | 2007-06-15 | Oreal | Composicion cosmetica y/o dermatologica para pieles sensibles. |
| US20060269508A1 (en) | 2005-03-29 | 2006-11-30 | Trejo Amy V | Means for regulating the cosmetic appearance and/or health of human keratinous tissue |
| EP1865795A1 (de) * | 2005-04-08 | 2007-12-19 | Alimentary Health Limited | Verfahren zur verwendung oral verabreichter probiotischer bifidobakterien zum nutzen der menschlichen schönheit |
| EP1885383B1 (de) | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Katzen probiotisches bifidobacterium |
| AR052472A1 (es) | 2005-05-31 | 2007-03-21 | Iams Company | Lactobacilos probioticos para felinos |
| AU2006262096B2 (en) * | 2005-06-21 | 2012-11-01 | Children's Hospital & Research Center At Oakland | Methods and compositions containing natural folates for protecting against radiation damage |
| FR2889057B1 (fr) * | 2005-08-01 | 2008-07-18 | Oreal | Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches |
| JP2007176879A (ja) * | 2005-12-28 | 2007-07-12 | Natl Inst Of Radiological Sciences | 酵母を有効成分とする放射線防護剤 |
| WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
| KR100868777B1 (ko) * | 2007-03-15 | 2008-11-17 | 재단법인서울대학교산학협력재단 | Ｒｓ３ 유형의 저항 전분에 대해 분해능이 있는비피도박테리움 아도레스센티스를 유효성분으로 함유하는것을 특징으로 하는 식품 조성물 |
| FR2919501B1 (fr) * | 2007-08-02 | 2010-12-31 | Oreal | Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees |
| FR2920306B1 (fr) * | 2007-09-04 | 2010-07-30 | Oreal | Utilisation cosmetique d'un lysat de bifidobacterieum species. |
| FR2920305B1 (fr) * | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
| CA2697735C (en) * | 2007-09-04 | 2014-02-18 | L'oreal | Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin |
| FR2920304B1 (fr) * | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
| FR2920300B1 (fr) * | 2007-09-04 | 2012-12-28 | Oreal | Utilisation d'une association hesperidine et microorganisme pour agir sur la fonction barriere de la peau. |
| FR2920307B1 (fr) * | 2007-09-04 | 2010-06-04 | Oreal | Utilisation cosmetique de microorganismes. |
| US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| JP5254682B2 (ja) * | 2008-06-27 | 2013-08-07 | 株式会社ヤクルト本社 | 経口摂取用皮膚性状改善剤 |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| FR2938437B1 (fr) | 2008-11-19 | 2020-03-27 | Société des Produits Nestlé S.A. | Utilisation cosmetique de microorganisme pour le traitement des peaux grasses |
| FR2942720B1 (fr) * | 2009-03-03 | 2024-01-19 | Oreal | Utilisation cosmetique d'hesperidine. |
| FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| WO2011083738A1 (ja) * | 2010-01-06 | 2011-07-14 | 株式会社ヤクルト本社 | 経口用のｄｎａ損傷修復促進剤及びエラスターゼ活性抑制剤 |
| CN103249420B (zh) | 2010-06-28 | 2016-06-29 | 株式会社益力多本社 | 口服用皮肤性状改善剂 |
| EP2449890A1 (de) * | 2010-11-05 | 2012-05-09 | Nestec S.A. | Getreidepulverzusammensetzungen mit nicht-replizierenden probiotischen Mikroorganismen |
| JP6073857B2 (ja) | 2011-04-08 | 2017-02-01 | セーホーエル．ハンセン アクティーゼルスカブ | 合成抗微生物効果 |
| HUE034259T2 (en) | 2012-04-09 | 2018-02-28 | Chr Hansen As | Biological protection using Lactobacillus rhamnosus strains |
| DK2836588T3 (en) | 2012-04-09 | 2017-05-22 | Chr Hansen As | Bioprotection using Lactobacillus paracasei strains |
| WO2015012421A1 (ko) * | 2013-07-23 | 2015-01-29 | 서원대학교 산학협력단 | 인체 유래 복합 균주를 이용한 발효물의 제조방법 및 상기 발효물을 함유한 기능성 화장료 조성물 |
| LT6463B (lt) | 2015-12-10 | 2017-10-10 | Uab "Probiosanus" | Probiotinių bakterijų (pb) gyvybingumo ir stabilumo padidinimas detergentų turinčiuose asmens higienos ir buities priežiūros produktuose |
| EP3222282A1 (de) * | 2016-03-21 | 2017-09-27 | Bionou Research, S.L. | Verwendung von probiotika bei der behandlung und/oder vorbeugung von psoriasis |
| KR102122652B1 (ko) * | 2018-09-07 | 2020-06-12 | 건국대학교 산학협력단 | 락토바실러스 루테리 제제를 이용한 피부개선용 조성물 |
| KR102011240B1 (ko) * | 2019-01-31 | 2019-08-14 | 에스케이바이오랜드 주식회사 | 신규한 락토바실러스 파라카제이 skb1192 균주 또는 이를 함유하는 광보호 효능이 있는 조성물 및 그 제품 |
| FR3097441B1 (fr) * | 2019-06-24 | 2021-06-25 | Oreal | Composition cosmétique comprenant un lysat deBifidobacterium species, un extrait de levure du genreSaccharomyces, et un monosaccharide mannose et ses utilisations cosmétiques |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3920834A (en) * | 1970-07-10 | 1975-11-18 | Hoffmann La Roche | Light-screening compositions and method |
| DE3024318A1 (de) * | 1980-06-27 | 1982-01-28 | Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin | Kosmetische mittel |
| US4646362A (en) * | 1985-01-10 | 1987-03-03 | Kimberly-Clark Corporation | Disposable underpants, such as child's training pants and the like |
| US4806368A (en) * | 1987-09-16 | 1989-02-21 | Reddy Malireddy S | Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation |
| US5223491A (en) * | 1989-11-09 | 1993-06-29 | Donzis Byron A | Method for revitalizing skin by applying topically water insoluble glucan |
| JPH0517363A (ja) * | 1991-07-11 | 1993-01-26 | Yakult Honsha Co Ltd | 抗炎症剤及びそれを含有する化粧料 |
| US5501857A (en) * | 1992-07-24 | 1996-03-26 | Midwestern Bio-Ag Products & Services, Inc. | Oral nutritional and dietary composition |
| JP3347381B2 (ja) * | 1993-01-27 | 2002-11-20 | 協和醗酵工業株式会社 | ペットフード |
| JPH0799932A (ja) * | 1993-09-30 | 1995-04-18 | Nippon Suisan Kaisha Ltd | ファフィア色素油を含有する健康食品 |
| FR2718752B1 (fr) * | 1994-04-15 | 1996-07-12 | World Trust Investment Sa | Préparations à base de lactosérum fermenté et leurs utilisations. |
| FR2725896B1 (fr) * | 1994-10-19 | 1996-11-29 | Sederma Sa | Nouvelles compositions cosmetiques ou dermopharmaceutiques |
| IT1274654B (it) * | 1995-02-28 | 1997-07-18 | Newpharma Srl | Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono |
| JPH0919283A (ja) * | 1995-07-06 | 1997-01-21 | Hisatoki Komaki | 乳酸菌及び酵母の菌体成分複合体の製造方法 |
| JPH0937711A (ja) * | 1995-07-28 | 1997-02-10 | Sennosuke Tokumaru | 健康食品 |
| JP3129646B2 (ja) * | 1996-01-19 | 2001-01-31 | 鐘紡株式会社 | セラミド合成促進剤 |
| US5795602A (en) * | 1996-04-12 | 1998-08-18 | Cargill, Incorporated | Milk enhancer and milk feed composition |
| FR2749758B1 (fr) * | 1996-06-12 | 1998-08-07 | Oenobiol Sa Lab | Composition a activite bronzante et photoprotectrice et ses applications esthetiques |
| AU6763198A (en) * | 1997-03-24 | 1998-10-20 | Viva America Marketing, Inc. | Stabilized solid bacteria compositions |
| EP0931543B1 (de) * | 1997-12-19 | 2002-03-20 | MERCK PATENT GmbH | Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien |
| JP4163276B2 (ja) * | 1998-02-05 | 2008-10-08 | 独立行政法人理化学研究所 | 機能性組成物 |
| US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
| NL1010770C2 (nl) * | 1998-12-09 | 2000-06-13 | Nutricia Nv | Preparaat dat oligosacchariden en probiotica bevat. |
| JP2003527432A (ja) * | 2000-03-24 | 2003-09-16 | ソシエテ デ プロデユイ ネツスル ソシエテ アノニム | 腹膜炎の治療のための乳酸菌の使用 |
| EP1151673A3 (de) * | 2000-05-03 | 2002-01-02 | Societe Des Produits Nestle S.A. | Konfekt mit Füllung |
| CA2313659A1 (en) * | 2000-07-06 | 2002-01-06 | Barry J. Barclay | B complex vitamin compositions that protect against cellular damage caused by ultraviolet light |
| US6864231B2 (en) * | 2001-01-09 | 2005-03-08 | Pharmachem Laboratories, Inc. | Glycoprotein matrix compositions and methods related thereto |
| CA2437931C (en) * | 2001-02-19 | 2011-11-01 | Societe Des Produits Nestle S.A. | Consumable product containing probiotics |
| US20040052852A1 (en) * | 2001-09-25 | 2004-03-18 | Michael Farber | Carbohydrate-based delivery system for creatine and other bioactive ingredients |
| RU2309760C2 (ru) * | 2002-02-21 | 2007-11-10 | Сосьете Де Продюи Нестле С.А. | Композиция для фотопротекции кожи |
| ES2462535T3 (es) * | 2002-02-21 | 2014-05-23 | Societe des Produits Nestlé S.A. | Composición de pienso para animales de compañía destinada a proteger la piel de la radiación solar |
-
2003
- 2003-02-18 UA UA20040907623A patent/UA78547C2/uk unknown
- 2003-02-18 WO PCT/EP2003/001686 patent/WO2003070260A1/en active IP Right Grant
- 2003-02-18 CN CNA038042908A patent/CN1635897A/zh active Pending
- 2003-02-18 KR KR10-2004-7013098A patent/KR20040096605A/ko not_active Application Discontinuation
- 2003-02-18 US US10/504,906 patent/US20050106131A1/en not_active Abandoned
- 2003-02-18 PL PL03372274A patent/PL372274A1/xx not_active Application Discontinuation
- 2003-02-18 PT PT03742551T patent/PT1490077E/pt unknown
- 2003-02-18 DK DK03742551T patent/DK1490077T3/da active
- 2003-02-18 CA CA2476730A patent/CA2476730C/en not_active Expired - Fee Related
- 2003-02-18 RU RU2004128078/15A patent/RU2314112C2/ru not_active IP Right Cessation
- 2003-02-18 JP JP2003569216A patent/JP2005525348A/ja active Pending
- 2003-02-18 ES ES03742551T patent/ES2297181T3/es not_active Expired - Lifetime
- 2003-02-18 BR BR0307839-6A patent/BR0307839A/pt not_active IP Right Cessation
- 2003-02-18 EP EP03742551A patent/EP1490077B1/de not_active Revoked
- 2003-02-18 DE DE60317646T patent/DE60317646T2/de not_active Expired - Lifetime
- 2003-02-18 MX MXPA04008182A patent/MXPA04008182A/es active IP Right Grant
- 2003-02-21 TW TW092103676A patent/TW200303211A/zh unknown
- 2003-02-24 AR ARP030100586A patent/AR038592A1/es not_active Application Discontinuation
-
2004
- 2004-09-15 NO NO20043873A patent/NO20043873L/no not_active Application Discontinuation
- 2004-09-20 ZA ZA200407549A patent/ZA200407549B/en unknown
-
2005
- 2005-12-20 US US11/314,043 patent/US20060099196A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040096605A (ko) | 2004-11-16 |
| NO20043873L (no) | 2004-09-15 |
| TW200303211A (en) | 2003-09-01 |
| RU2314112C2 (ru) | 2008-01-10 |
| PT1490077E (pt) | 2008-02-28 |
| AU2003210310A1 (en) | 2003-09-09 |
| DE60317646D1 (de) | 2008-01-03 |
| EP1490077B1 (de) | 2007-11-21 |
| WO2003070260A1 (en) | 2003-08-28 |
| CA2476730A1 (en) | 2003-08-28 |
| US20060099196A1 (en) | 2006-05-11 |
| UA78547C2 (en) | 2007-04-10 |
| AR038592A1 (es) | 2005-01-19 |
| CN1635897A (zh) | 2005-07-06 |
| MXPA04008182A (es) | 2005-06-08 |
| EP1490077A1 (de) | 2004-12-29 |
| US20050106131A1 (en) | 2005-05-19 |
| DK1490077T3 (da) | 2009-05-04 |
| DE60317646T2 (de) | 2008-10-30 |
| JP2005525348A (ja) | 2005-08-25 |
| RU2004128078A (ru) | 2005-04-20 |
| PL372274A1 (en) | 2005-07-11 |
| BR0307839A (pt) | 2004-12-07 |
| ES2297181T3 (es) | 2008-05-01 |
| CA2476730C (en) | 2012-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2476730C (en) | A photoprotective orally administrable composition for skin | |
| AU2003232184B2 (en) | Orally administrable composition for the photoprotection of the skin | |
| CA2424607C (en) | Use of probiotic lactic acid bacteria for balancing the skin's immune system | |
| AU2003210311C1 (en) | Pet food composition for skin photoprotection | |
| AU2003210310B2 (en) | A photoprotective orally administrable composition for skin |